Journal for ImmunoTherapy of Cancer (Nov 2023)

1153 BCG022: a HER3×MET bispecific antibody-drug conjugate (BsADC) targeting key mechanisms of bypass resistance in multiple tumor types

  • Yi Yang,
  • W Frank An,
  • Chaoshe Guo,
  • Chengzhang Shang,
  • Gao An,
  • Zhuolin Li,
  • Zhenyan Han

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1153
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.